We’ve created the world’s most efficient AI platform for rare diseases. It makes drug discovery faster, smarter and safer, and supports our team and partners in discovering and translating new treatments towards the clinic.
Our collaborations with patient groups allow us to accelerate treatment discovery
Rare Treatment Accelerator
Our Rare Treatment Accelerator programme connects academic, patient and industry groups with Healx. Working together, we can quickly turn your research, insights and clinic-ready repurposing assets into treatments that will benefit rare disease patients.Learn more
Discovering and moving at a completely different scale
Experts in drug discovery
Since 2014, we have successfully grown our pipeline of projects and partnerships. We have a number of projects finishing their preclinical validation and we are running another number of in silico discoveries for future projects.
By leveraging public biomedical databases, scientific literature and proprietary curated data, the technologies that make up our AI platform Healnet can fill in critical knowledge gaps in rare diseases. They also cross-validate each other’s results and present preformed, data-driven hypotheses with unmatched speed and accuracy.